{
    "title": "Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.",
    "abstract": "OCs containing ethinyl estradiol and gestodene increase, to a clinically significant extent, the plasma concentrations and effects of tizanidine, probably mainly by inhibiting its CYP1A2-mediated presystemic metabolism. Care should be exercised when tizanidine is prescribed to OC users.",
    "pmid": 16198659,
    "authors": [
        {
            "first_name": "Marika T",
            "last_name": "Granfors"
        },
        {
            "first_name": "Janne T",
            "last_name": "Backman"
        },
        {
            "first_name": "Jouko",
            "last_name": "Laitila"
        },
        {
            "first_name": "Pertti J",
            "last_name": "Neuvonen"
        }
    ]
}